Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$5.81
+0.5%
$5.92
$5.26
$11.38
$232.75M0.66571,564 shs313,347 shs
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$0.82
+1.2%
$0.93
$0.78
$4.29
$44.48M0.58154,414 shs96,074 shs
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
$2.19
$2.18
$1.98
$4.48
$100.11M0.5394,654 shs91,205 shs
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$65.92
-0.6%
$69.64
$65.91
$100.59
$236.65M0.1226,496 shs22,564 shs
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-1.53%-5.56%+7.04%-3.99%-30.28%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-1.55%+1.00%-9.10%-18.28%-67.11%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-0.45%+6.31%+1.86%+3.79%-47.10%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
-1.30%-1.40%-2.71%-20.96%-30.11%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
4.0069 of 5 stars
3.52.00.04.21.13.30.6
Cytosorbents Co. stock logo
CTSO
Cytosorbents
0.6817 of 5 stars
3.32.00.00.00.00.00.6
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
1.3628 of 5 stars
3.51.00.00.00.62.50.6
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
2.4145 of 5 stars
0.03.01.74.22.11.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
3.00
Buy$14.25145.27% Upside
Cytosorbents Co. stock logo
CTSO
Cytosorbents
2.50
Moderate Buy$2.50205.25% Upside
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
3.00
Buy$3.5059.82% Upside
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/AN/AN/AN/A

Current Analyst Ratings

Latest CTSO, ANGO, KRMD, and UTMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/5/2024
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$12.00
3/15/2024
Cytosorbents Co. stock logo
CTSO
Cytosorbents
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$1.00
3/14/2024
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
$338.75M0.69$1.08 per share5.36$5.46 per share1.06
Cytosorbents Co. stock logo
CTSO
Cytosorbents
$36.35M1.22N/AN/A$0.52 per share1.58
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
$28.52M3.51N/AN/A$0.45 per share4.87
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$50.22M4.71$6.22 per share10.60$35.35 per share1.86

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
-$52.44M-$4.84N/AN/AN/A-60.21%-3.48%-2.68%7/10/2024 (Estimated)
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-$28.51M-$0.64N/AN/AN/A-78.43%-120.24%-54.11%5/7/2024 (Estimated)
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-$13.74M-$0.29N/AN/AN/A-48.18%-27.82%-21.30%5/1/2024 (Confirmed)
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$16.64M$4.5714.42N/A33.12%13.53%12.68%7/23/2024 (Estimated)

Latest CTSO, ANGO, KRMD, and UTMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-$0.04N/A+$0.04N/AN/AN/A  
3/14/2024Q4 2023
Cytosorbents Co. stock logo
CTSO
Cytosorbents
-$0.14-$0.12+$0.02-$0.12$9.29 million$8.67 million
3/13/2024Q4 2023
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
-$0.04-$0.02+$0.02$0.12$7.01 million$7.19 million
1/30/2024Q4 2023
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A$1.18+$1.18$1.18N/A$12.33 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/AN/AN/AN/AN/A
Cytosorbents Co. stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
N/AN/AN/AN/AN/A
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$1.201.82%+1.75%26.26%2 Years

Latest CTSO, ANGO, KRMD, and UTMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
quarterly$0.301.6%3/14/20243/15/20244/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
N/A
2.29
1.62
Cytosorbents Co. stock logo
CTSO
Cytosorbents
0.11
1.77
1.51
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
0.02
4.55
3.77
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A
22.56
20.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
89.43%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
32.87%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
58.60%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
69.60%

Insider Ownership

CompanyInsider Ownership
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
5.10%
Cytosorbents Co. stock logo
CTSO
Cytosorbents
8.10%
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
25.60%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
6.50%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AngioDynamics, Inc. stock logo
ANGO
AngioDynamics
81540.06 million38.01 millionOptionable
Cytosorbents Co. stock logo
CTSO
Cytosorbents
18654.31 million49.91 millionOptionable
KORU Medical Systems, Inc. stock logo
KRMD
KORU Medical Systems
8245.71 million34.01 millionOptionable
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
1693.59 million3.36 millionNot Optionable

CTSO, ANGO, KRMD, and UTMD Headlines

SourceHeadline
UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024UTMD Stock Earnings: Utah Medical Products Reported Results for Q1 2024
investorplace.com - April 26 at 12:04 AM
Utah Medical Products EPS of $1.10, revenue of $11.3MUtah Medical Products EPS of $1.10, revenue of $11.3M
msn.com - April 25 at 5:08 PM
Utah Medical: Q1 Earnings SnapshotUtah Medical: Q1 Earnings Snapshot
washingtonpost.com - April 25 at 10:31 AM
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
accesswire.com - April 25 at 9:00 AM
Utah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-savingUtah mom fights for her daughter’s access to discontinued diabetes medication: ‘Life-saving'
msn.com - April 19 at 7:30 AM
Fairmat opens first U.S. industrial facility in UtahFairmat opens first U.S. industrial facility in Utah
compositesworld.com - April 18 at 3:57 PM
Hurdles in Utah push medical cannabis patients toward out-of-state products.Hurdles in Utah push medical cannabis patients toward out-of-state products.
cityweekly.net - April 17 at 6:18 PM
Advance directives help people plan for their future medical care and quality of lifeAdvance directives help people plan for their future medical care and quality of life
msn.com - April 12 at 5:30 PM
2 Beaten-Down Stocks That Could Be Ready to Soar2 Beaten-Down Stocks That Could Be Ready to Soar
fool.com - April 11 at 5:33 AM
Utah Department of Agriculture unveils new analysis of Utahs Medical Cannabis marketUtah Department of Agriculture unveils new analysis of Utah's Medical Cannabis market
cachevalleydaily.com - April 9 at 4:39 PM
Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestoneIntermountain Health’s Transplant Program and patients celebrate life-saving medical milestone
msn.com - March 14 at 10:05 PM
Utah at the forefront of Americas alarming prescription drug shortagesUtah at the forefront of America's alarming prescription drug shortages
ksl.com - March 12 at 6:37 PM
Utah at the forefront of America’s alarming prescription drug shortagesUtah at the forefront of America’s alarming prescription drug shortages
msn.com - March 11 at 9:12 PM
Utah Valleys 1st osteopathic college to host grand opening for innovative buildingUtah Valley's 1st osteopathic college to host grand opening for 'innovative' building
ksl.com - March 4 at 2:15 PM
Utah Medical Products, Inc.s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 4 at 8:49 AM
Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiumsUtah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums
msn.com - March 3 at 9:18 AM
Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outageUtah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage
msn.com - February 25 at 2:35 PM
Utah affected by E. coli contamination in raw milk cheeseUtah affected by E. coli contamination in raw milk cheese
news.yahoo.com - February 18 at 2:20 PM
Utah Medical Products, Inc. Announces Quarterly DividendUtah Medical Products, Inc. Announces Quarterly Dividend
finance.yahoo.com - February 6 at 12:42 PM
Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)
finance.yahoo.com - January 31 at 5:58 PM
Utah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUtah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finanznachrichten.de - January 30 at 7:07 PM
UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finance.yahoo.com - January 30 at 7:07 PM
Utah Medical Products Inc (UTMD) Reports Mixed 2023 Financial ResultsUtah Medical Products Inc (UTMD) Reports Mixed 2023 Financial Results
finance.yahoo.com - January 30 at 7:07 PM
Investors Could Be Concerned With Utah Medical Products (NASDAQ:UTMD) Returns On CapitalInvestors Could Be Concerned With Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
finance.yahoo.com - January 26 at 11:24 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AngioDynamics logo

AngioDynamics

NASDAQ:ANGO
AngioDynamics, Inc. provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease. The company's thrombus management portfolio includes AlphaVac system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac circuit is indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. In addition, it offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. The company also provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
Cytosorbents logo

Cytosorbents

NASDAQ:CTSO
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.
KORU Medical Systems logo

KORU Medical Systems

NASDAQ:KRMD
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
Utah Medical Products logo

Utah Medical Products

NASDAQ:UTMD
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.